期刊文献+

雷奈酸锶对大鼠骨质疏松性骨折愈合的骨密度及骨微结构影响 被引量:4

The effect of strontium ranelate on bone mineral density and bone microstructure in rat osteoporotic fracture healing
下载PDF
导出
摘要 目的观察雷奈酸锶对大鼠胫骨骨质疏松性骨折愈合过程中的骨密度、骨微结构及愈合后生物力学特性的影响。方法 72只雌性SD大鼠卵巢去势制造骨质疏松模型,造模成功后制造开放性骨折并予克氏针内固定。术后分为对照组和治疗组,分别给予生理盐水和雷奈酸锶625mg/(kg.d)灌胃给药。结果在治疗后6、8w时两组骨性愈合率并无明显差异,但Micro CT检验数据结果显示治疗组骨密度(BMD);骨小梁体积(BV)、组织体积(TV)、骨体积分数(BV/TV)、平均骨小梁厚度(Tb.Th)、平均骨小梁数目(Tb.N)均明显高于对照组(P<0.05),且治疗组最大压缩荷载在治疗后4w(48.1±5.6(治疗组)vs 21.8±4.8(对照组))、8w时亦明显高于对照组(96.5±9.7(治疗组)vs68.2±7.4(对照组))。结论雷奈酸锶能够抑制骨折后的骨量丢失,增加骨密度,促进骨折愈伤组织的生长,改善骨小梁三维结构及骨组织的力学性能,可用来促进骨质疏松性骨折的愈合并改善骨质量,预防再骨折。 Objective This study was designed to investigate the influence of strontium ranelate in bone mineral density (BMD), bone microstructure, and bone biomeehanieal characteristics during the bone healing after osteoporotic fracture in rats. Methods Seventy-two SD rats were ovariectomized to establish osteoporosis model. They were then performed open fracture and fixed with Kirschner's needle. After the surgery, rats were divided into treatment group (treated with strontium ranelate 625mg/kg/day) and control group ( lavaged with normal saline). Results The bone healing was not different between the two groups 6- and 8-week after the surgery. According to micro-CT results, BMD, bone volume (BV) , tissue volume ( TV), bone volume ratio ( BV/TV), trabecular thickness (Tb. Th), and trabecular number (Tb. N) in the treatment group were significantly higher than those in control group. The maximal loadings in the treatment group were significantly elevated than those in control group on 4 weeks (48.1 ± 5.6N vs 21.8 ±4.8N) and 8 weeks (96.5 ±9.7N vs 68.2 ±7.4N) after the surgery. Conclusions Strontium rauelate can inhibit bone loss after bone fracture. It can increase BMD, stimulate fracture-healing tissue growth, improve trabecular 3D structure and biomechanical strength. It can be applied in stimulating osteoporosis bone fracture healing, improving bone quality, and preventing of further fracture.
出处 《中国骨质疏松杂志》 CAS CSCD 2011年第10期868-872,共5页 Chinese Journal of Osteoporosis
关键词 骨质疏松性骨折 雷奈酸锶 骨折愈合 骨微结构 Osteoporotic fracture Strontium ranelate Fracture healing Bone microstructure
  • 相关文献

参考文献15

  • 1Johnson-Lynn SE, Francis R, McCaskie A. Osteoporosis treatments and their effect on fracture healing. Current Orthopaedics, 2008,22 ( 5 ) : 556-540.
  • 2Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fi'acture in women with postmenopausal osteoporosis. N Engl J Med, 2004,350: 459- 468.
  • 3Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis : Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab, 2005, 90, 2816-2822.
  • 4Canalis E, Hott M, Deloffre P, et al. The divalent strontiumsah S12911 enhances bone cell replication and bone formation in vitro. Bone 1996,18:517-523.
  • 5Azria M. Possible mechanisms of the analgesic action of calcitonin. Bone, 2002, 30:80-83.
  • 6Brennan T, Rybchyn M, Green W, et al. Osteoblasts play key roles in the mechanisms of action of strontium ranelatc. Br J Pharmacol,2009, 157 : 1291-1300.
  • 7Cao Y, Mori S, Mashiba T, et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res, 2002, 17 (2) : 2237- 2246.
  • 8Schmidmaier G, Wildemann B, Melis B, ct al. Development and characterization of a standard closed tibial fracture model in the rat. Eur J Trauma,2OOd, 30:35-42.
  • 9Rene Rizzoli, Michel Laroche, Marc-Antoine Krieg, et al. Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis. Rheumatol lnt, 2010,30 : 1341-1348.
  • 10Reginster JY, Bruyere O, Sawicki A, et al. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years. Bone,2009,45 (6) : 1059-1064.

同被引文献42

  • 1彭松林,吕维加,夏仁云,方煌,李锋,陆瓞骥.锶盐对骨质疏松大鼠骨微结构的影响[J].中国骨与关节外科,2008,1(1):40-43. 被引量:2
  • 2刘忠厚,杨定焯,朱汉民,王洪复,张柳,唐海,赵燕玲.中国人原发性骨质疏松症诊断标准(试行)[J].中国骨质疏松杂志,1999,5(1):1-3. 被引量:244
  • 3徐丹,袁凤易,王新民.钙与维生素D防治骨质疏松的循证医学研究进展[J].国外医学(内分泌学分册),2005,25(5):338-341. 被引量:16
  • 4张俊,葛宁,黄晓丽,张新军.骨质疏松症的药物治疗评价[J].中国实用内科杂志:临床前沿版,2006,26(2):313-315. 被引量:25
  • 5刘学军.骨质疏松症[J].中国矫形外科杂志,2006,14(21):1668-1670. 被引量:26
  • 6Neuprez A, H iligsmann M, Schohissen S, et al. Stron- tium ranelate: the first agent of a new therapeutic class in osteoporosis [J]. Adv Ther, 2008, 25 ( 12 ) : 1235 - 1256.
  • 7Cao Y, Mori S, Mashiba T, et al. Raloxifene, estrogen and alendronate affect the processes of fracture repair differently in ovarieetomized rats[J] J Bone Miner Res,2002,17(12) :2237 - 2246.
  • 8McDonald MM, Dulai S, Godfrey C, et al. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing en- hances delays in hard callus remodeling [J]. Bone, 2008,43(4) :653 - 662.
  • 9Gerstenfeld LC, Sacks DJ, Pelis M, et al. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing[J]. J Bone Miner Res,2009,24(2) :196 - 208.
  • 10Riggs BL,Parfitt AM.Drugs used to treat osteoporosis:The critical need for a uniform nomenclature based on their action on bone remodeling[J].J Bone Miner Res,2005,20(2):177-184.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部